Clinical Trials
8 trialsNCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT06120712 2025-12-23
MIZAR-002
Shanghai Juncell Therapeutics
Phase 1/2 Completed
NCT05652673 2025-02-28
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
Erasmus Medical Center
Phase NA Recruiting
NCT03638375 2023-12-12
ACTME
Leiden University Medical Center
Phase 1/2 Unknown
NCT00006345 2013-05-30
Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00002759 2013-02-05
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003269 2011-01-10
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Scripps Health
Phase 2 Completed
NCT00221702 2010-10-13
EADO
University Hospital, Bordeaux
Phase 3 Completed